The 11th annual Amgen Tour of California presented by AEG entered its second decade as America's most prestigious annual cycling event, welcoming an unsurpassed field of professional teams for the race start in San Diego. One of the most important races on the international calendar, the 8'day event attracts some of the brightest cycling stars in the world to the golden state each May. This year’s field features 11 World Champions, five Olympic medalists and Rio Olympic hopefuls, with more than 30 countries represented.
The 2016 Amgen Tour of California includes 10 UCI WorldTour Teams, the most in race history, as some of the top cyclists in the world face off across nearly 800 miles of California terrain May 15-22, visiting 12 Host Cities from San Diego to Sacramento.
2016 marks the debut of the UCI Women's WorldTour, which brings the highest level of professional women's cycling competition to cities around the world. The four-day Amgen Breakaway from Heart Disease Women's Race Empowered with SRAM May 19-22 marks the U.S. debut of the Women’s WorldTour and will showcase some of the best talent in the sport. The peloton will include two-time Olympic champion Kristin Armstrong and eight Rio Olympic hopefuls.
The eight-stage men’s event began Sunday with 18 of the world’s most decorated and esteemed teams competing for one of the sport’s most coveted titles. World Champion and reigning race champion Peter Sagan of Tinkoff roared to victory in a bunch sprint to the finish line in Mission Beach, San Diego, putting him back into the yellow leader jersey he wore at the race’s conclusion last year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7831951-amgen-tour-of-california/
On Saturday, May 21, some of the biggest names in the entertainment industry celebrated the 90th birthday of the legendary Tony Bennett at Keep Memory Alive’s 20th annual Power of Love® gala at the MGM Grand Garden Arena in Las Vegas. The star-studded event raised funds and awareness for Cleveland Clinic Lou Ruvo Center for Brain Health and its fight against brain disease including Alzheimer’s, Huntington’s and Parkinson’s diseases, multiple sclerosis and multiple system atrophy.
Highlights from the night included a performance by honoree Tony Bennett and heartfelt tributes by James Corden, Andra Day, Herbie Hancock, Darius Rucker, Jordin Sparks, Steven Tyler and more. Day kicked off the show with her rendition of “Steppin’ Out With My Baby,” while Corden performed his version of “Don’t Get Around Much More.” Later in the evening, Sparks teamed up with pianist Dan Orlando to perform a medley of hits including “The Best Is Yet To Come,” “Alright OK You Win” and “It Don’t Mean A Thing.” Rucker treated guests to hit single “Sunny Side of The Street,” before Hancock took the stage to perform “Chameleon” and “Cantaloupe Island.” Tyler joined the elite ensemble to perform “Smile” with jazz trumpeter Chris Botti before singing Aerosmith classic “I Don’t Want To Miss A Thing.” The man of the evening, Bennett, performed numerous hits including “Watch What Happens” and “How Do You Keep The Music Playing.” To close the show, the entire cast sang Bennett “Happy Birthday” and presented him with a celebratory cake. In addition to musical icons, celebrity supporters who also attended the event included Quincy Jones, Brad Garrett, Steve Schirripa and Chazz Palminteri.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842951-keep-memory-alive-tony-bennett/
As another school year ends, American parents once again face the challenge of making sure their kids get enough daily physical activity to keep them occupied throughout the summer. Based on the results of a recent national survey of parents with children ages 3-17, that may be easier said than done.
While the U.S. Centers for Disease Control and Prevention recommends that kids have at least 60 minutes of daily physical activity, the Let’s Play 2016 State of Play Survey, commissioned by Dr Pepper Snapple Group (NYSE: DPS), revealed that only one out of three children participates in daily active play.
There also appears to be a significant drop in daily active play when most children head off to kindergarten. Half of 4-year-olds get active daily playtime, compared to 31 percent of 5-year-olds.
To view the multimedia release go to:
http://www.multivu.com/players/English/7816051-dr-pepper-snapple-lets-play/
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine.
Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season.
“Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research.
Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
In celebration of National Seafood Month, the Seafood Nutrition Partnership is asking Americans to take the Healthy Heart Pledge and eat at least two servings of seafood each week in an effort to raise awareness around seafood’s health benefits.
Eating at least two servings of seafood each week, which is recommended by the USDA’s Dietary Guidelines for Americans, provides a variety of health benefits. Seafood is one of the leanest proteins and high in healthy fats known as omega-3s, which are essential for heart and brain health. Additionally, an estimated 50,000 deaths from heart disease and stroke are avoided every year by eating fish.
To view the multimedia release go to:
http://www.multivu.com/players/English/7928951-seafood-healthy-heart-pledge/
Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Every 23 seconds, someone in the United States is diagnosed with diabetes. It's estimated that one in 11 Americans has the disease—more than 29 million people—and another 86 million have prediabetes and are at risk for developing type 2 diabetes. The numbers alone are staggering, and the people affected by the disease include those who have diabetes and their friends, family, caregivers and communities.
American Diabetes Month®, observed by the American Diabetes Association® (Association) every November, is a time to focus the nation's attention on the many people who are affected by diabetes and to raise the urgency about the need to address diabetes. To help spark a national conversation, the Association is asking people to share their stories about what it truly means to live with diabetes with a new campaign, This Is Diabetes™.
To view the multimedia release go to:
http://www.multivu.com/players/English/7711431-american-diabetes-month-thisisdiabetes/
Ever since Donna and John met at work three decades ago, they've had the kind of smooth, comfortable relationship that comes when attraction is accompanied by compatible interests as well as strengths and weaknesses that balance each other. They pictured their senior years as an extension of what Donna Dean calls “this nice, easy life. We didn't see the calamity that was coming.”
Brookdale Senior Living, the nation's largest dementia care provider, has created new resources for care partners as part of National Alzheimer's Awareness Month in November. The candid discussion of many of the disease's most difficult challenges includes an up-close look at Donna's and John’s lives since he developed dementia.
To view the multimedia release go to:
http://www.multivu.com/players/English/7722131-brookdale-alzheimers-awareness/
